Acute coronary syndromes

people who are intolerant to ACE inhibitors, an ARB instead of an ACE inhibitor. [2013] 1.4.10 Renal function, serum electrolytes and blood pressure should be measured before starting an ACE inhibitor or ARB and again within 1 or 2 weeks of starting treatment. People should have appropriate monitoring as the dose is titrated upwards, until the maximum tolerated or target dose is reached, and then at least annually. More frequent monitoring may be needed in people who are at increased risk of deterioration in renal function. People with chronic heart failure should be monitored in line with the NICE guideline on chronic heart failure in adults. [2007] 1.4.11 Offer an ACE inhibitor to people who have had an MI more than 12 months ago. Acute coronary syndromes (NG185) Titrate to the maximum tolerated or target dose (over a 4- to 6-week period) and continue indefinitely. [2013] 1.4.12 Offer people who have had an MI more than 12 months ago and who are intolerant to ACE inhibitors an ARB instead of an ACE inhibitor. [2013] Antiplatelet therapy 1.4.13 Offer aspirin to all people after an MI and continue it indefinitely, unless they are aspirin intolerant or have an indication for anticoagulation
